Medacta Group SA (SWX:MOVE)
Switzerland · Delayed Price · Currency is CHF 113.40
-0.20 (-0.18%)
Oct 2, 2026, 5:30 PM CET
Medacta Group Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Medacta Group stock has a consensus rating of "Buy" and an average price target of CHF 162.83. The average 1-year stock price forecast is 43.59% higher than the current stock price, while the lowest is CHF 121.38 (+7.04%) and the highest is CHF 193.04 (+70.23%).
Price Target: CHF 162.83 (+43.59%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Medacta Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Hold Initiates CHF 121.00 | Hold | Initiates | CHF 121.00 | +6.70% | Sep 15, 2026 |
| Berenberg Bank | Berenberg Bank | Buy Maintains CHF 185.00 → CHF 180.00 | Buy | Maintains | CHF 185.00 → CHF 180.00 | +58.73% | Sep 11, 2026 |
| UBS | UBS | Hold Maintains CHF 151.00 → CHF 148.00 | Hold | Maintains | CHF 151.00 → CHF 148.00 | +30.51% | Jul 21, 2026 |
Financial Forecast
Revenue This Year
752.10M
from 683.83M
Increased by 9.98%
Revenue Next Year
859.16M
from 752.10M
Increased by 14.23%
EPS This Year
4.76
from 4.33
Increased by 9.80%
EPS Next Year
5.67
from 4.76
Increased by 19.13%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.